PMAQX
Price
$48.54
Change
+$0.35 (+0.73%)
Updated
Jul 25 closing price
Net Assets
33.03B
RSSYX
Price
$25.42
Change
+$0.20 (+0.79%)
Updated
Jul 25 closing price
Net Assets
83.17M
Interact to see
Advertisement

PMAQX vs RSSYX

Header iconPMAQX vs RSSYX Comparison
Open Charts PMAQX vs RSSYXBanner chart's image
Principal MidCap R6
Price$48.54
Change+$0.35 (+0.73%)
VolumeN/A
Net Assets33.03B
Victory RS Select Growth Y
Price$25.42
Change+$0.20 (+0.79%)
VolumeN/A
Net Assets83.17M
PMAQX vs RSSYX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
PMAQX vs. RSSYX commentary
Jul 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PMAQX is a Buy and RSSYX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
PMAQX has more cash in the bank: 33B vs. RSSYX (83.2M). PMAQX pays higher dividends than RSSYX: PMAQX (0.19) vs RSSYX (0.00). PMAQX was incepted earlier than RSSYX: PMAQX (9 years) vs RSSYX (16 years). RSSYX (1.30) is less costly to investors than PMAQX (0.59). RSSYX is a more actively managed with annual turnover of: 129.00 vs. PMAQX (10.50). PMAQX has a lower initial minimum investment than RSSYX: PMAQX (0) vs RSSYX (1000000). PMAQX annual gain was more profitable for investors over the last year : 13.16 vs. RSSYX (10.91). PMAQX return over 5 years is better than : 57.67 vs. RSSYX (-35.33).
PMAQXRSSYXPMAQX / RSSYX
Total Expense Ratio0.591.1452%
Annual Report Gross Expense Ratio0.591.3045%
Fund Existence9 years16 years-
Gain YTD7.977-3.112-256%
Front LoadN/AN/A-
Min. Initial Investment01000000-
Min. Initial Investment IRAN/AN/A-
Net Assets33B83.2M39,663%
Annual Yield % from dividends0.190.00-
Returns for 1 year13.1610.91121%
Returns for 3 years49.764.731,051%
Returns for 5 years57.67-35.33-163%
Returns for 10 yearsN/A-51.47-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CHSCP27.720.17
+0.62%
CHS
NLOP33.420.19
+0.57%
Net Lease Office Properties
CLDX23.350.13
+0.56%
Celldex Therapeutics
MUR26.13-0.20
-0.76%
Murphy Oil Corp
IPSC0.63-0.03
-5.17%
Century Therapeutics